| Trial ID: | L1439 |
| Source ID: | NCT01942460
|
| Associated Drug: |
Ferumoxytol
|
| Title: |
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Iron-Deficiency Anemia|Inflammation|Oxidative Stress
|
| Interventions: |
DRUG: Ferumoxytol
|
| Outcome Measures: |
Primary: Change in hemoglobin, serum ferritin and transferrin saturation, 4 weeks following ferumoxytol administration | Secondary: Change in inflammatory markers (C-reactive protein and Interleukin-6), 60 minutes following ferumoxytol administration|Change in oxidative stress markers (Malondialdehyde, Advance Oxidation Protein Products, Non Transferrin-bound Iron), 60 minutes following ferumoxytol administration|Change in soluble transferrin receptor, 4 weeks following ferumoxytol administration
|
| Sponsor/Collaborators: |
Sponsor: Georges Ouellet
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-09
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-13
|
| Locations: |
Hôpital Maisonneuve-Rosemont, Montréal, Quebec, H1T 2M4, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT01942460
|
